Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway

Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway

Yuan Cao,1– 3 Yulin Li,1– 3 Wenqiang Han,1– 3 Xu Jia,1– 3 Ping Zhu,1– 3 Bin Wei,4 Xiaoyan Cong,5,6 Zhihao Wang7,8 1Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Jinan, Peop...

Full description

Bibliographic Details
Main Authors: Cao Y, Li Y, Han W, Jia X, Zhu P, Wei B, Cong X, Wang Z
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Journal of Inflammation Research
Subjects:
diabetes mellitus
sarcopenia
ilc2s
sodium butyrate
il-13
Online Access:https://www.dovepress.com/sodium-butyrate-ameliorates-type-2-diabetes-related-sarcopenia-through-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/sodium-butyrate-ameliorates-type-2-diabetes-related-sarcopenia-through-peer-reviewed-fulltext-article-JIR

Similar Items